Eminase

BACKGROUND QT dispersion (QTd; QT interval maximum minus minimum) has been shown to reflect regional variations in ventricular… Expand

 

OBJECTIVES The presence of thrombus formation and type of coronary artery lesion were determined in patients with unstable angina… Expand

One measure of the success of thrombolysis is the early patency status of the infarct-related coronary artery. The Thrombolysis… Expand

Interest in early thrombolysis has prompted a study on the feasibility and time course of prehospital thrombolysis in patients… Expand

In this article we report on the development, introduction, and maintenance of a policy to promote rational use of thrombolytic… Expand

Eminase (anistreplase), or anisoylated plasminogen streptokinase activator complex (APSAC), is a reversibly inactivated lys… Expand

Anistreplase, a modified congener of streptokinase, is a recently approved thrombolytic agent used in the treatment of acute… Expand

Abstract The stability of the novel thrombolytic agent APSAC (anisovlated lys 77 -plasminogen-streptokinase activator complex) in… Expand

Tissue Plasminogen Activator (t-PA), Single Chain Urokinase Plasminogen Activator or pro-Urokinase (scu-PA or pro-UK) and acyl… Expand